论文部分内容阅读
通过对60例AMT患者的临床研究,旨在评价镁盐防治AMI早期心律失常的疗效。治疗组30例患者给予硫酸镁+极化液缓慢静脉滴注,疗程10d;对照组给予极化液。结果表明,缓慢静脉滴注适当剂量和足够疗程的镁盐,才能彻底纠正机体(主要是细胞内)缺镁,从而有效地防治AMI的心律失常。根据镁盐治疗前后血浆、红细胞和尿镁含量,以及∑ST、∑T和心功能的动态变化,对镁盐的作用进行初步探讨。本研究为临床提供了一种有效而且安全治疗AMI的方法。
Through the clinical study of 60 patients with AMT, the purpose is to evaluate the efficacy of magnesium salt in preventing and treating AMI in the early stage. Thirty patients in the treatment group were treated with slow intravenous infusion of magnesium sulfate and pooled solution for 10 days. The control group was given the pooled solution. The results show that slow intravenous infusion of adequate dose and adequate treatment of magnesium salts, in order to completely correct the body (mainly intracellular) magnesium deficiency, which effectively prevent arrhythmia AMI. According to the changes of plasma, erythrocytes and urinary magnesium before and after magnesium salt treatment, and the dynamic changes of ΣST, ΣT and cardiac function, the effects of magnesium salt were discussed. This study provides an effective and safe method for the clinical treatment of AMI.